NeOnc's Breakthrough Discovery
We are committed to a world free from the fear of brain cancer. Our mission is to pursue innovative solutions that enhance patient care, bring hope, and extend lives. We aim to transform the standard of care for treating brain and Central Nervous System diseases through our dedication to research, close collaboration with medical professionals, and personalized care that always places patients and their families at the center of everything we do.
Breaking Through Barriers: NeOnc's Delivery Revolution
NeOnc has developed a proprietary, patented platform technology designed to transport therapeutics directly to the brain, overcoming the limitations of the Blood-Brain Barrier (BBB). Our innovative formulations offer pharmaceutical companies a new pathway to deliver potentially more effective treatments for Central Nervous System (CNS) diseases, expanding possibilities for patients.
The Problem
The potential for greater success in treating devastating CNS diseases like Glioblastoma has long been severely limited. The primary hurdle is the persistent inability to effectively and directly deliver therapeutic agents to the brain, a challenge that has historically prevented many promising treatments from reaching their full potential.
Our Solution
Our proprietary approaches and patented technologies are delivering new therapies for brain cancers. We also facilitate the transport of established and new therapeutics across the blood-brain barrier, significantly improving their efficacy for treating a wide range of brain diseases.
The Potential
By regulating tumor cell growth and providing a powerful transport mechanism for therapeutics, we plan to equip doctors and healthcare professionals with the tools to deliver significantly better outcomes for their patients.
Our Latest Research & Study
NeOnc maintains an aggressive regimen of research and study into our therapeutic delivery and formulations. This commitment ensures our continued ability to impact the treatment of CNS-based diseases.
NEO100 Research Shows Impact On Recurrent Grade 4 Astrocytoma
NEO100 Intranasal Delivery Technology Shows Promise for Better Therapeutic Results.
Study Shows NEO400 Has Therapeutic Effect On UV-Induced Skin Damage
NEO100 Enhances Entry And Therapeutic Activity Of Chimeric Antigen Receptor T Cells
Transfemoral Injection of NEO100 Provides Potential for Delivery of Therapeutics to the Brain
Postsurgical Biopsy Shows Viability of NEO100 Intranasal Delivery
Investing in the Future of CNS Therapeutics
Our commitment to advancing brain and Central Nervous System therapeutics drives our mission to create enduring value for patients and stakeholders alike. We believe our relentless pursuit of innovative solutions to transform the standard of care is a catalyst for long-term growth. Through a focused dedication to research, strategic collaboration with leading medical professionals, and a patient-centric approach, we are positioned to deliver impactful treatments and robust returns. Our groundbreaking work is not only about bringing hope and extending lives, it’s about building a sustainable and valuable enterprise for the future.
